Lack of Indian Consensus on the sequencing of therapy in Metastatic Colorectal Cancer
Despite global consensus on treatments for metastatic colorectal cancer targeting different mutations like EGFR, VEGF, and HER2, the Indian context lacks clarity. The client, large sized Indian pharma, wanted to help establish the same in India which is capture in the case study below. Collaborating closely with Indian oncologists, we analyzed local data and practices, revealing insights crucial for optimizing therapies like Cetuximab and Bevacizumab. This effort led to the publication of the Indian Consensus in a peer-reviewed journal, bridging the gap and guiding tailored treatment approaches nationwide.
We have an excellent team to give you the best service of caregiving and take care of your loved ones. If you want to explore more about us and give us a chance to get you our finest service, book an appointment today and become a part of our community.
